TLC BioSciences Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	89.44	189.17
Revenue Growth	-52.72%	-
Cost of Revenue	15.51	62.92
Gross Profit	73.93	126.25
Selling, General & Admin	133.39	233.39
Research & Development	579.59	781.47
Operating Expenses	712.97	1,015
Operating Income	-639.05	-888.62
Interest Expense	-126.04	-144.96
Interest & Investment Income	34.26	74
Other Non Operating Income (Expenses)	82.19	-1,250
Pretax Income	-648.64	-2,210
Income Tax Expense	4.61	0.67
Earnings From Continuing Operations	-653.25	-2,211
Minority Interest in Earnings	-	24.87
Net Income	-653.25	-2,186
Net Income to Common	-653.25	-2,186
Net Income Growth	-	-
Shares Outstanding (Basic)	83	77
Shares Outstanding (Diluted)	83	77
Shares Change	8.65%	-
EPS (Basic)	-7.84	-28.50
EPS (Diluted)	-7.84	-28.50
EPS Growth	-	-

Additional Metrics